Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports

Pfizer (PFE.N) has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.